Presence of residual beta cells and co-existing islet autoimmunity in the NOD mouse during longstanding diabetes: A combined histochemical and immunohistochemical study

Journal of Molecular Histology

Volumn 39, Issue 1, 2008, Pages 25-36

  Reddy, Shiva ^a   Chai, Ryan Chau Chia ^a   Rodrigues, Jessica Astrid ^a   Hsu, Tzu Hsuan ^a   Robinson, Elizabeth ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Beta cells; Diabetes; Glucose transporter 2; Insulitis; NOD mouse

Indexed keywords

GLUCAGON; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; SOMATOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INSULITIS; MACROPHAGE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD3; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCOSE TRANSPORTER TYPE 2; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; MACROPHAGES; MICE; MICE, INBRED NOD;

MUS;

EID: 38349177483     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10735-007-9122-5     Document Type: Article

References (29)

1. Assan R, Feutren G, Sirmai J, Laborie C, Boitard C, Vexiau P, Rostu HD, Rodier M, Figoni M, Vague P, Hors J, Bach J-F (1990) Plasma C-peptide levels and clinical remissions in recent-onset type 1 diabetic patients treated with cyclosporine A and insulin. Diabetes 39:768-774
2. Bonner-Weir S (2000) Islet growth and development in the adult. J Mol Endocrinol 24:297-302
3. Bottazzo GF, Dean BM, McNally JM, McKay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. New Engl J Med 313:353-360
4. Charlton B, Bacelj A, Slattery RM, Mandel TE (1989) Cyclophosphamide- induced diabetes in NOD/WEHI mice: evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes 38:441-447
5. Eisenbarth GS, Connelly J, Soeldner JS (1987) The "natural" history of type 1 diabetes. Diabetes Metab Rev 3:873-891
6. Foulis AK, Stewart JA (1984) The pancreas in recent-onset Type 1(insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26:456-461
7. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in Type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267-274
8. Foulis AK, McGill M, Farquharson MA (1991) Insulitis in Type 1 (insulin-dependent) diabetes mellitus in man- macrophages, lymphocytes and interferon-γ containing cells. J Pathol 165:97-103
9. Gepts W (1965) Pathological anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-633
10. Gepts W, De Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1):251-261
11. Hashimoto T, Kawano H, Daikoku S, Shima K, Taniguchi H, Baba S (1988) Transient co-appearance of glucagon and insulin in the progenitor cells of the rat pancreatic islets. Anat Embryol 178:489-497
12. Kano Y, Kanatsuna T, Nakamura N, Kitagawa Y, Mori H, Kajiyama S, Nakano K, Kondo M (1986) Defect of the first-phase insulin secretion to glucose stimulation in the perfused pancreas of the nonobese diabetic (NOD) mouse. Diabetes 35:486-490
13. Li Z, Karlsson FA, Sandler S (2000) Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice. J Endocrinol 165:93-99
14. Lohr M, Kloppel G (1987) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic Type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757-762
15. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221-2228
16. O'Reilley LA, Gu D, Sarvetnick N, Edlund H, Phillips JM, Fulford T, Cooke A (1997) α-Cell neogenesis in an animal model of IDDM. Diabetes 46:599-606
17. Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW (2004) C-Peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA Workshop, 21-22 October 2001. Diabetes 53:250-264
18. Reddy S, Bibby NJ, Elliott RB (1988) Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse. Diabetologia 31:322-328
19. Reddy S, Wu D, Swinney C, Elliott RB (1995) Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse. Pancreas 11:16-25
20. Reddy S, Young M, Poole CA, Ross JM (1998) Loss of glucose transporter-2 precedes insulin loss in the non-obese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy. Gen Comp Endocrinol 111:9-19
21. Reddy S, Yip S, Karanam M, Poole CA, Ross JM (1999) An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide. Histochem J 31:303-314
22. Reddy S, Bradley J, Ginn S, Pathipati P, Ross JM (2003) Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes. Histochem Cell Biol 119:451-461
23. Reddy S, Pathipathi P, Bai Y, Robinson E, Ross JM (2005) Histopathological changes in insulin, glucagon and somatostatin cells in the islets of NOD mice during cyclophosphamide-accelerated diabetes: a combined immunohistochemical and histochemical study. J Mol Histology 36:289-300
24. Thorens B (1992) Molecular and cellular physiology of GLUT-2, a high-Km facilitated diffusion glucose transporter. Int Rev Cytol 137A:209-238
25. Somoza N, Vargas F, Roura-Mir C, Vives-Pi M, Fernandez-Figueras MT, Ariza A, Gomis R, Bragado R, Marti M, Jaraquemada D, Pujol-Burel R (1994) Pancreas in recent-onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor Vβ usage, and cytokine profile. J Immunol 153:1360-1377
26. Stefan Y, Orci L, Malaisse-Lagae F, Perrelet A, Patel A, Unger RH (1982) Quantitation of endocrine cell content in the pancreas of non-diabetic and diabetic humans. Diabetes 31:694-700
27. Rahier J, Goebbels RM, Henquin JC (1983) Cellular composition of the human diabetic pancreas. Diabetologia 24:366-371
28. Suarez-Pinzon WL, Yan Y, Power R, Brand SJ, Rabinovitch A (2005) Combination therapy with epidermal growth factor and gastrin increases β-cell mass and reverses hyperglycaemia in diabetic NOD mice. Diabetes 54:2596-2601
29. Uno S, Imagagwa A, Okita K, Sayama K, Moriwaki M, Iwahashi J, Yamaga K, Tamura S, Matsuzawa Y, Hanafusa T, Miyagawa J, Shimomura I (2007) Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-α in patients with recent-onset type 1 diabetes. Diabetologia 50:596-601